| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 |
|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||
Net Income (Loss) Attributable to Parent | |||||||
-50,339 | -46,106 | -46,216 | -46,226 | -40,741 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | |||||||
2,337 | 2,113 | 1,943 | 1,779 | 1,692 | 0 | 0 | 0 |
Capitalized Contract Cost, Amortization | |||||||
7,780 | 6,895 | 6,095 | 5,303 | 4,495 | 0 | 0 | 0 |
Stock-based compensation | |||||||
27,205 | 22,608 | 25,437 | 20,733 | 19,078 | 0 | 0 | 0 |
Bad debt expense | |||||||
- | - | - | 0 | - | - | - | 0 |
Changes in operating assets and liabilities: | |||||||
Accounts receivable | |||||||
3,601 | 4,886 | 10,110 | 13,885 | 15,464 | 0 | 0 | 0 |
Deferred contract costs | |||||||
15,996 | 15,830 | 14,807 | 14,403 | 13,809 | 0 | 0 | 0 |
Prepaid expenses and other assets | |||||||
2,112 | 5,330 | 2,402 | 2,275 | 2,914 | 0 | 0 | 0 |
Accounts payable | |||||||
-1,110 | -349 | -827 | 1,490 | 1,356 | 0 | 0 | 0 |
Accrued expenses and other liabilities | |||||||
3,668 | 2,268 | 5,058 | 2,457 | 1,931 | 0 | 0 | 0 |
Accrued compensation | |||||||
3,861 | 7,955 | 4,568 | 3,263 | 5,176 | 0 | 0 | 0 |
Deferred revenue | |||||||
28,465 | 28,878 | 28,220 | 25,027 | 25,935 | 0 | 0 | 0 |
Net cash used in operating activities | |||||||
-173 | -1,347 | -1,968 | -8,864 | -5,608 | 0 | 0 | 0 |
Cash flows from investing activities | |||||||
Purchases of property and equipment | |||||||
5,174 | 3,842 | 5,185 | 4,538 | 3,730 | 0 | 0 | 0 |
Net cash used in investing activities | |||||||
-232,070 | -173,499 | -40,178 | -4,927 | -4,119 | 0 | 0 | 0 |
Cash flows from financing activities | |||||||
Proceeds from initial public offering, net of underwriters' discounts and commissions | |||||||
220,086 | 220,086 | 220,086 | 220,086 | 0 | 0 | 0 | 0 |
Payments of Stock Issuance Costs | |||||||
5,945 | 6,048 | 5,653 | 4,368 | 445 | 0 | 0 | 0 |
Proceeds from repayment of promissory note | |||||||
515 | 515 | 515 | 515 | 0 | 0 | 0 | 0 |
Proceeds from issuance of common stock upon exercise of stock options | |||||||
7,187 | 5,970 | 3,712 | 3,459 | 1,525 | 0 | 0 | 0 |
Proceeds from early exercised stock options, net of repurchases | |||||||
0 | -7 | -7 | 2,234 | 2,227 | 0 | 0 | 0 |
Net cash provided by financing activities | |||||||
225,944 | 220,502 | 308,935 | 312,218 | 93,599 | 0 | 0 | 0 |
Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||||
-6,299 | 45,656 | 266,789 | 298,427 | 83,872 | 0 | 0 | 0 |
Supplemental cash flow data: | |||||||
Cash paid for taxes | |||||||
73 | 53 | 77 | 35 | 45 | 0 | 0 | 0 |
Non-cash investing and financing activities: | |||||||
Vesting of early exercised options | |||||||
1,342 | 1,343 | 1,345 | 1,158 | 883 | 0 | 0 | 0 |
Purchase of property and equipment, accrued but not yet paid | |||||||
1,463 | 91 | -1,487 | 1,056 | 82 | 0 | 0 | 0 |
Costs related to initial public offering, accrued but not yet paid | |||||||
0 | 2,913 | 3,553 | 4,857 | 2,816 | 0 | 0 | 0 |